Steven Dodd

Steven Dodd has a strong background in business development and sales strategy within the pharmaceutical and clinical research industry. Steven began their career at PPD in 1992 as an Executive Director of Business Development, a role they held until 2007. Steven then joined MDS Pharma Services as Vice President of Global Business Development, and later became Executive Director of Business Development. In 2010, they joined Covance Laboratories as Global Key Account Director for Analytical Services, and later became Executive Director of Global Key Accounts. In 2014, they returned to PPD as Executive Director of Business Development for Vaccines. In 2015, they transitioned to the role of Executive Director of Business Development for Bioanalytical and Vaccine Services. Steven joined ICON plc in 2020 as Executive Director of Sales Strategy, and currently serves as Vice President of ICON Early Clinical and Bioanalytical Services.

Steven Dodd earned a Bachelor of Science degree in Chemistry from Randolph-Macon College between the years 1988 and 1992.